| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.557 |
Evidence |
|
| RALA |
RALA, RAL: Ras-related protein Ral-A precursor |
GRK1 |
GRK1, RHOK: Rhodopsin kinase precursor |
0.557 |
Evidence |
|
| LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
PRELP |
PRELP: Prolargin precursor |
0.557 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
P2RY6 |
P2RY6, PP2891: P2Y purinoceptor 6 |
0.557 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
PTGER1 |
PTGER1: Prostaglandin E2 receptor EP1 subtype |
0.557 |
Evidence |
|
| OPN1SW |
OPN1SW, BCP: Blue-sensitive opsin |
NPFFR1 |
NPFFR1, GPR147, NPFF1: Neuropeptide FF receptor 1 |
0.557 |
Evidence |
|
| OPN1SW |
OPN1SW, BCP: Blue-sensitive opsin |
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
0.557 |
Evidence |
|
| OPN1SW |
OPN1SW, BCP: Blue-sensitive opsin |
GPR3 |
GPR3, ACCA: Probable G-protein coupled receptor 3 |
0.557 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
RELB |
RELB: Transcription factor RelB |
0.557 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
P2RY11 |
P2RY11: P2Y purinoceptor 11 |
0.557 |
Evidence |
|
| EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.557 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
0.557 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
GPR1 |
GPR1: Probable G-protein coupled receptor 1 |
0.557 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
0.557 |
Evidence |
|
| EDG5 |
EDG5: Sphingosine 1-phosphate receptor Edg-5 |
EDG6 |
EDG6: Sphingosine 1-phosphate receptor Edg-6 |
0.557 |
Evidence |
|
| PPFIA3 |
PPFIA3, KIAA0654: Liprin-alpha-3 |
IRS2 |
IRS2: Insulin receptor substrate 2 |
0.557 |
Evidence |
|
| GPR39 |
GPR39: Probable G-protein coupled receptor 39 |
SSTR5 |
SSTR5: Somatostatin receptor type 5 |
0.557 |
Evidence |
|
| FFAR2 |
FFAR2, GPR43: Free fatty acid receptor 2 |
GALR2 |
GALR2, GALNR2: Galanin receptor type 2 |
0.557 |
Evidence |
|
| GPR42 |
GPR42: Putative G-protein coupled receptor 42 |
PTGER3 |
PTGER3: Prostaglandin E2 receptor EP3 subtype |
0.557 |
Evidence |
|
| GPR42 |
GPR42: Putative G-protein coupled receptor 42 |
NMBR |
NMBR: Neuromedin-B receptor |
0.557 |
Evidence |
|
| TP73 |
TP73, P73: Tumor protein p73 |
CCNB2 |
CCNB2: G2/mitotic-specific cyclin-B2 |
0.557 |
Evidence |
|
| TNFRSF13B |
TNFRSF13B, TACI: Tumor necrosis factor receptor superfamily member 13B |
TNFRSF4 |
TNFRSF4, TXGP1L: Tumor necrosis factor receptor superfamily member 4 precursor |
0.557 |
Evidence |
|
| GPR171 |
GPR171, H963: Probable G-protein coupled receptor 171 |
GPR109B |
GPR109B: Nicotinic acid receptor 2 |
0.557 |
Evidence |
|
| CCBP2 |
CCBP2, CCR10, CMKBR9: Chemokine-binding protein 2 |
CCR10 |
CCR10, GPR2: C-C chemokine receptor type 10 |
0.557 |
Evidence |
|
| P2RY10 |
P2RY10: Putative P2Y purinoceptor 10 |
OR51E2 |
OR51E2, PSGR: Olfactory receptor 51E2 |
0.557 |
Evidence |
|